Histone deacetylase inhibition overcomes drug resistance through a miRNA-dependent mechanism

Molecular Cancer Therapeutics

Volumn 12, Issue 10, 2013, Pages 2088-2099

  Murray Stewart, Tracy ^a   Hanigan, Christin L ^a   Woster, Patrick M ^b   Marton, Laurence J ^c   Casero Jr , Robert A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(N1,N12) BIS(ETHYL) 6,7 DEHYDROSPERMINE TETRAHYDROCHLORIDE; ENTINOSTAT; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MICRORNA; MICRORNA 200A; N1,N11 DIETHYLNORSPERMINE; PG 11047; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CANCER RESISTANCE; CATABOLISM; DRUG POTENTIATION; ENZYME DEGRADATION; ENZYME INHIBITION; EPIGENETICS; GENE; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; PHENOTYPE; PRIORITY JOURNAL; RNA TRANSLATION; SSAT GENE;

ACETYLTRANSFERASES; BENZAMIDES; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; METABOLIC NETWORKS AND PATHWAYS; METABOLISM; MICRORNAS; POLYAMINES; PROMOTER REGIONS, GENETIC; PYRIDINES; SPERMINE;

EID: 84885674655     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-13-0418     Document Type: Article

References (52)

1. Nowotarski SL, Woster PM, Casero RA Jr. Polyamines and cancer: implications for chemotherapy and chemoprevention. Expert Rev Mol Med 2013;15:e3.
2. Snyder RD. Polyamine depletion is associated with altered chromatin structure in HeLa cells. Biochem J 1989;260: 697-704.
3. BalasundaramD, Tyagi AK. Polyamine-DNA nexus: structural ramifications and biological implications. Mol Cell Biochem 1991;100: 129-40.
4. Feuerstein BG, Pattabiraman N, Marton LJ. Molecular mechanics of the interactions of spermine with DNA: DNA bending as a result of ligand binding. Nucleic Acids Res 1990;18: 1271-82.
5. Reddy VK, Valasinas A, Sarkar A, Basu HS, Marton LJ, Frydman B. Conformationally restricted analogues of 1N,12N-bisethylspermine: synthesis and growth inhibitory effects on human tumor cell lines. J Med Chem 1998;41: 4723-32.
6. Smith MA, Maris JM, Lock R, Kolb EA, Gorlick R, Keir ST, et al. Initial testing (stage 1) of the polyamine analog PG11047 by the pediatric preclinical testing program. Pediatr Blood Cancer 2011;57: 268-74.
7. Casero RA Jr, Celano P, Ervin SJ, Porter CW, Bergeron RJ, Libby PR. Differential induction of spermidine/spermine N1-acetyltransferase in human lung cancer cells by the bis(ethyl)polyamine analogues. Cancer Res 1989;49: 3829-33.
8. Devereux W, WangY, Stewart TM, Hacker A, Smith R, Frydman B, et al. Induction of the PAOh1/SMO polyamine oxidase by polyamine analogues in human lung carcinoma cells. Cancer Chemother Pharmacol 2003;52: 383-90.
9. Pledgie A, Huang Y, Hacker A, Zhang Z, Woster PM, Davidson NE, et al. Spermine oxidase SMO(PAOh1), not N1-acetylpolyamine oxidase PAO, is the primary source of cytotoxic H2O2 in polyamine analogue-treated human breast cancer cell lines. J Biol Chem 2005;280: 39843-51.
10. Dredge K, Kink JA, Johnson RM, Bytheway I, Marton LJ. The polyamine analog PG11047 potentiates the antitumor activity of cisplatin and bevacizumab in preclinical models of lung and prostate cancer. Cancer Chemother Pharmacol 2009;65: 191-5.
11. Hacker A, Marton LJ, Sobolewski M, Casero RA Jr. In vitro and in vivo effects of the conformationally restricted polyamine analogue CGC- 11047 on small cell and non-small cell lung cancer cells. Cancer Chemother Pharmacol 2008;63: 45-53.
12. Holst CM, Frydman B, Marton LJ, Oredsson SM. Differential polyamine analogue effects in four human breast cancer cell lines. Toxicology 2006;223: 71-81.
13. Kuo WL, Das D, Ziyad S, Bhattacharya S, Gibb WJ, Heiser LM, et al. A systems analysis of the chemosensitivity of breast cancer cells to the polyamine analogue PG-11047. BMC Med 2009;7:77.
14. Ignatenko NA, Yerushalmi HF, Pandey R, Kachel KL, Stringer DE, Marton LJ, et al. Gene expression analysis of HCT116 colon tumorderived cells treated with the polyamine analog PG-11047. Cancer Genomics Proteomics 2009;6: 161-75.
15. Cirenajwis H, Smiljanic S, Honeth G, Hegardt C, Marton LJ, Oredsson SM. Reduction of the putative CD44+CD24- breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047. Anticancer Drugs 2010;21: 897-906.
16. Fogel-Petrovic M, Shappell NW, Bergeron RJ, Porter CW. Polyamine and polyamine analog regulation of spermidine/spermine N1-acetyltransferase in MALME-3M human melanoma cells. J Biol Chem 1993;268: 19118-25.
17. Xiao L, Casero RA Jr. Differential transcription of the human spermidine/ spermine N1-acetyltransferase (SSAT) gene in human lung carcinoma cells. Biochem J 1996;313(Pt 2): 691-6.
18. Wang Y, Xiao L, Thiagalingam A, Nelkin BD, Casero RA Jr. The identification of a cis-element and a trans-acting factor involved in the response to polyamines and polyamine analogues in the regulation of the human spermidine/spermine N1-acetyltransferase gene transcription. J Biol Chem 1998;273: 34623-30.
19. Wang Y, Devereux W, Stewart TM, Casero RA Jr. Cloning and characterization of human polyamine-modulated factor-1, a transcriptional cofactor that regulates the transcription of the spermidine/ spermine N(1)-acetyltransferase gene. J Biol Chem 1999;274: 22095-101.
20. Casero RA Jr, Mank AR, Xiao L, Smith J, Bergeron RJ, Celano P. Steady-state messenger RNA and activity correlates with sensitivity to N1,N12-bis(ethyl)spermine in human cell lines representing the major forms of lung cancer. Cancer Res 1992;52: 5359-63.
21. Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 1999;13: 76-86.
22. Singh A, Misra V, Thimmulappa RK, Lee H, Ames S, Hoque MO, et al. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med 2006;3:e420.
23. Lachner M, O'Sullivan RJ, Jenuwein T. An epigenetic road map for histone lysine methylation. J Cell Sci 2003;116: 2117-24.
24. Jenuwein T, Allis CD. Translating the histone code. Science 2001;293: 1074-80.
25. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006;6: 107-16.
26. Wang B, Zhu X, Kim Y, Li J, Huang S, Saleem S, et al. Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage. Free Radic Biol Med 2012;52: 928-36.
27. Eades G, Yang M, Yao Y, Zhang Y, Zhou Q. miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells. J Biol Chem 2011;286: 40725-33.
28. Piekarz RL, Bates SE. Epigenetic modifiers: basic understanding and clinical development. Clin Cancer Res 2009;15: 3918-26.
29. Bergeron RJ, Neims AH, McManis JS, Hawthorne TR, Vinson JR, Bortell R, et al. Synthetic polyamine analogues as antineoplastics. J Med Chem 1988;31: 1183-90.
30. Babbar N, Hacker A, Huang Y, Casero RA Jr. Tumor necrosis factor alpha induces spermidine/spermine N1-acetyltransferase through nuclear factor kappaB in non-small cell lung cancer cells. J Biol Chem 2006;281: 24182-92.
31. Murray-Stewart T, Wang Y, Goodwin A, Hacker A, Meeker A, Casero RA Jr. Nuclear localization of human spermine oxidase isoforms- possible implications in drug response and disease etiology. FEBS J 2008;275: 2795-806.
32. Wang Y, Murray-Stewart T, Devereux W, Hacker A, Frydman B, Woster PM, et al. Properties of purified recombinant human polyamine oxidase, PAOh1/SMO. Biochem Biophys Res Commun 2003; 304: 605-11.
33. Kabra PM, Lee HK, Lubich WP, Marton LJ. Solid-phase extraction and determination of dansyl derivatives of unconjugated and acetylated polyamines by reversed-phase liquid chromatography: improved separation systems for polyamines in cerebrospinal fluid, urine and tissue. J Chromatogr 1986;380: 19-32.
34. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72: 248-54.
35. Porter CW, Sufrin JR. Interference with polyamine biosynthesis and/or function by analogs of polyamines or methionine as a potential anticancer chemotherapeutic strategy. Anticancer Res 1986;6: 525-42.
36. Porter CW, Bergeron RJ. Enzyme regulation as an approach to interference with polyamine biosynthesis-an alternative to enzyme inhibition. Adv Enzyme Regul 1988;27: 57-79.
37. Mitchell JL, Thane TK, Sequeira JM, Marton LJ, Thokala R. Antizyme and antizyme inhibitor activities influence cellular responses to polyamine analogs. Amino Acids 2007;33: 291-7.
38. Casero RA Jr, Marton LJ. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat Rev Drug Discov 2007;6: 373-90.
39. Seiler N, Atanassov CL, Raul F. Polyamine metabolism as target for cancer chemoprevention (review). Int J Oncol 1998;13: 993-1006.
40. Seiler N. Pharmacological aspects of cytotoxic polyamine analogs and derivatives for cancer therapy. Pharmacol Ther 2005;107: 99-119.
41. Lima e Silva R, Kachi S, Akiyama H, Shen J, Hatara MC, Aslam S, et al. Trans-scleral delivery of polyamine analogs for ocular neovascularization. Exp Eye Res 2006;83: 1260-7.
42. Coleman CS, Huang H, Pegg AE. Role of the carboxyl terminal MATEE sequence of spermidine/spermine N1-acetyltransferase in the activity and stabilization by the polyamine analog N1,N12-bis(ethyl)spermine. Biochemistry 1995;34: 13423-30.
43. Casero RA, Pegg AE. Polyamine catabolism and disease. Biochem J 2009;421: 323-38.
44. Libby PR, Bergeron RJ, Porter CW. Structure-function correlations of polyamine analog-induced increases in spermidine/spermine acetyltransferase activity. Biochem Pharmacol 1989;38: 1435-42.
45. Murray-Stewart T, Applegren NB, Devereux W, Hacker A, Smith R, Wang Y, et al. Spermidine/spermine N1-acetyltransferase (SSAT) activity in human small-cell lung carcinoma cells following transfection with a genomic SSAT construct. Biochem J 2003;373: 629-34.
46. McCloskey DE, Pegg AE. Properties of the spermidine/spermine N1- acetyltransferase mutant L156F that decreases cellular sensitivity to the polyamine analogue N1, N11-bis(ethyl)norspermine. J Biol Chem 2003;278: 13881-7.
47. Feuerstein BG, Basu HS, Marton LJ. Theoretical and experimental characterization of polyamine/DNA interactions. Adv Exp Med Biol 1988;250: 517-23.
48. Eades G, Yao Y, Yang M, Zhang Y, Chumsri S, Zhou Q. miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells. J Biol Chem 2011;286: 25992-6002.
49. Tellez CS, Juri DE, Do K, Bernauer AM, Thomas CL, Damiani LA, et al. EMT and stem cell-like properties associated with miR-205 and miR- 200 epigenetic silencing are early manifestations during carcinogeninduced transformation of human lung epithelial cells. Cancer Res 2011;71: 3087-97.
50. Vrba L, Jensen TJ, Garbe JC, Heimark RL, Cress AE, Dickinson S, et al. Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells. PLoS ONE 2010;5:e8697.
51. Hahm HA, Ettinger DS, Bowling K, Hoker B, Chen TL, Zabelina Y, et al. Phase I study of N(1),N(11)-diethylnorspermine in patients with nonsmall cell lung cancer. Clin Cancer Res 2002;8: 684-90.
52. Wolff AC, Armstrong DK, Fetting JH, Carducci MK, Riley CD, Bender JF, et al. A Phase II study of the polyamine analog N1,N11-diethylnorspermine (DENSpm) daily for five days every 21 days in patients with previously treated metastatic breast cancer. Clin Cancer Res 2003;9: 5922-8.